Related Experiment Video
Updated: Feb 13, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
Natalizumab: Perspectives from the Bench to Bedside.
Afsaneh Shirani1, Olaf Stüve1,2
1Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Natalizumab, a monoclonal antibody for multiple sclerosis, targets lymphocyte trafficking by blocking α4-integrin. Despite rapid development, its post-approval history includes withdrawal due to progressive multifocal leukoencephalopathy and subsequent reinstatement with strict monitoring.
Area of Science:
- Neuroimmunology
- Pharmacology
- Drug Development
Background:
- Natalizumab is a monoclonal antibody used to treat relapsing remitting multiple sclerosis.
- It functions by inhibiting lymphocyte trafficking into the central nervous system via α4-integrin blockade.
- The drug's development timeline from target discovery to approval was notably rapid.
Purpose of the Study:
- To provide a comprehensive overview of natalizumab's journey.
- To discuss its efficacy and safety profile.
- To highlight the challenges and successes in its post-marketing surveillance.
Main Methods:
- Review of scientific literature and regulatory documents.
- Analysis of clinical trial data and post-marketing surveillance reports.
- Examination of the mechanism of action and its clinical implications.
Main Results:
- Natalizumab demonstrated significant efficacy in reducing multiple sclerosis relapses.
- An unforeseen risk of progressive multifocal leukoencephalopathy (PML) emerged post-approval.
- Reintroduction of natalizumab was accompanied by risk mitigation strategies and patient monitoring.
Conclusions:
- Natalizumab represents a significant advancement in multiple sclerosis treatment.
- The drug's history underscores the importance of rigorous post-marketing surveillance.
- Careful patient selection and monitoring are crucial for managing the risks associated with natalizumab therapy.
Related Concept Videos
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Carl Rogers' Humanistic Perspective on Personality
The organism refers to an individual's inherent blueprint, which Rogers saw as innately positive and directed toward helping others, unlike Freud's view of the id as driven by base impulses. The self is a person's...

